Overview

Internal pilot and definitive cluster Randomised Control Trial (Staring 2023)

We will carry out the definitive trial of the CHARMER intervention across up to 42 hospitals. We will assess the CHARMER intervention in terms of safety, effectiveness and cost effectiveness. We will also develop recommendations about the CHARMER intervention process and characteristics to help people implement it in the future. We will use processes developed and refined from Work Package 3 (the feasibility trial) to inform all Work Package 4 procedures.

Patient and public involvement in this stage of the research will involve collaborating with the work package team to design patient participant materials. It will also contributing to the analysis of qualitative data to provide transparency and validation of interpretations.

jjjjPublic and Patient Involvement

Work Package Team

Megan Pritchard
Trial Manager, Norwich Clinical Trials Unit, University of East Anglia
Amber Hammond
Clinical Trial Assistant, Norwich Clinical Trials Unit, University of East Anglia
David Alldred
Professor of Medicines Use and Safety, University of Leeds
David Wright
Professor of Health Services Research, University of Leicester / CHARMER Co-Chief Investigator
Allan Clark
Senior Lecturer in Medical Statistics, University of East Anglia
David Taylor
David Turner
Senior Research Fellow in Health Economics, University of East Anglia
Katherine Murphy
Patient and Public Involvement & Media Relations Lead
Janet Gray
Patient and Public Involvement

Collaborating Organisations